A A A A
 
Pages
Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Posts
Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Menu
 
 
Home | Governance
 

Leadership

Precision-Panc was established in 2017 as a research collaboration with the majority of funding coming from Cancer Research UK (CRUK). It is led by Prof. Andrew Biankin, Dr David Chang (University of Glasgow), Prof. Juan Valle (University of Manchester), Prof. Owen Sansom (Cancer Research UK Beatson Institute), Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit), Professor Caroline Dive (University of Manchester), Professor Chris Lord (ICR), Professor Duncan Jodrell (CRUK institute Cambridge), Professor Eric O’Neil (University of Oxford) as joint lead investigators, as well as a Steering Committee.

For a complete list of grantholders, investigators and committee members, visit Meet The Team.  

Steering Committee

The Steering Committee is comprised of grantholders, investigators, a patient representative, and a representative of CRUK. Additional collaborators, including a representative of the US-based Precision Promise initiative, are also invited to participate.

Its remit is to: 

  • Provide oversight of the Precision-Panc Programme, track its progress and take steps to keep it on course for completion on time and within budget;
  • Agree mechanisms for project management and progress reporting;
  • Agree indicators of success;
  • Provide a forum for project management and issue resolution, as well as risk and incident management;
  • Ensure that appropriate ethics approvals and consents are obtained for the purposes of the funded work;
  • Actively seek and identify opportunities for publishing results, make recommendations to Investigators who may wish to prepare publications of results, and support the drafting and preparation of publications of results in accordance with the Cancer Research UK Grant Conditions 

Therapeutic Testing Board

The Therapeutic Testing Board is a forum to discuss the pre-clinical work that should inform the clinical trials led by Precision-Panc. Any investigator is invited to present a trial concept to the board, which will then assess the platform of evidence to translate that concept into a new trial.  The board may suggest additional preclinical experiments and next steps to adopt the concept or alter it in order to meet new trial criteria.

If you would like to submit a proposal to the Therapeutic Testing Board, please email contact@precisionpanc.org

Scientific Advisory Board

The Scientific Advisory Board is comprised of eight external scientific experts who have distinguished themselves in the area of cancer genetics/genomics/clinical trials, in addition to at least one patient advocate. Through annual meetings, the group will advise and guide the project throughout its lifetime. 

Its remit is to:

  • Provide insight into the quality of the project deliverables and the scientific, technical and methodological progress of the project;
  • Advise on the plans for dissemination, international discussion and promotion of the project and its associated results.

Umbrella Trials Steering Committee

The Umbrella Trial Steering Committee is run through the CRUK Clinical Trials Unit Glasgow to oversee all Precision-Panc trials run at the Glasgow Clinical Trials Unit.  

Precision-Panc Patient Advisory Group

The Precision-Panc Patient Advisory Group is a group of patient and carers identified via Pancreatic Cancer UK’s Research Involvement Network and Cancer Research UK’s Your Involvement Network to provide insight and guidance into our research efforts.

Its remit is to:

  • Review and develop key message documents for both patients and healthcare professionals; 
  • Review the Precision-Panc website and provide suggestions for updates;
  • Participate on the Precision-Panc Steering Committee, Scientific Advisory Board and Umbrella Trials Steering Committee;
  • Provide consultations for Precision-Panc researchers including reviewing patient facing material such as the patient information sheets as well as ensuring all protocol investigations required by a study would be acceptable to patients.

External Networks

Precision-Panc is also represented throughout the pancreatic cancer network, both in the UK and abroad, including:

© 2019 Precision Panc
Web design by Creatomatic
This site uses cookies.
Configure
 
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.